Search results for the GEO ID: GSE2842
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM60535
GPL570
Adult-B-ALL-24h Adult B-ALL patient, peripheral blood biological source: homo sapiens, childhood ALL patient (male, aged 72 years), peripheral blood taken 24h after GC-monotherapy initiation homo sapiens, childhood ALL patient (male, aged 72 years), peripheral blood taken 24h after GC-monotherapy initiation
GSM60536
GPL570
Adult-B-ALL-6h Adult B-ALL patient, peripheral blood biological source: homo sapiens, childhood ALL patient (male, aged 72 years), peripheral blood taken 6h after GC-monotherapy initiation, leukocyte isolation CD10 targeted enrichment for malignant blasts homo sapiens, childhood ALL patient (male, aged 72 years), peripheral blood taken 6h after GC-monotherapy initiation, leukocyte isolation CD10 targeted enrichment for malignant blasts
GSM60537
GPL570
Adult-B-ALL-0h Adult B-ALL patient, peripheral blood biological source: homo sapiens, ALL patient (male, aged 72 years), peripheral blood taken prior to treatment, leukocyte isolation CD10 targeted enrichment for malignant blasts. biological source: homo sapiens, ALL patient (male, aged 72 years), peripheral blood taken prior to treatment, leukocyte isolation CD10 targeted enrichment for malignant blasts.
GSM60538
GPL570
IV-B-ALL-40-6h-EtOH B-ALL patient 40, peripheral blood biological source: homo sapiens, ALL ex vivo material from adult B-ALL patient, peripheral blood taken prior to treatment, leukocyte isolation CD10 targeted enrichment for malignant blasts, cultivated in the presence of ethanol 0,1% for 6h biological source: homo sapiens, ALL ex vivo material from adult B-ALL patient, peripheral blood taken prior to treatment, leukocyte isolation CD10 targeted enrichment for malignant blasts, cultivated in the presence of ethanol 0,1% for 6h
GSM60539
GPL570
IV-B-ALL-40-6h-GC B-ALL patient 40, peripheral blood biological source: homo sapiens, ALL ex vivo material from adult B-ALL patient, peripheral blood taken prior to treatment, leukocyte isolation CD10 targeted enrichment for malignant blasts, cultivated in the presence of dexamethasone 10e-7M for 6h biological source: homo sapiens, ALL ex vivo material from adult B-ALL patient, peripheral blood taken prior to treatment, leukocyte isolation CD10 targeted enrichment for malignant blasts, cultivated in the presence of dexamethasone 10e-7M for 6h
GSM60540
GPL570
IV-B-ALL-40-24h-EtOH B-ALL patient 40, peripheral blood biological source: homo sapiens, ALL ex vivo material from adult B-ALL patient, peripheral blood taken prior to treatment, leukocyte isolation CD10 targeted enrichment for malignant blasts, cultivated in the presence of ethanol 0,1% for 24h biological source: homo sapiens, ALL ex vivo material from adult B-ALL patient, peripheral blood taken prior to treatment, leukocyte isolation CD10 targeted enrichment for malignant blasts, cultivated in the presence of ethanol 0,1% for 24h
GSM60541
GPL570
IV-B-ALL-40-24h-GC B-ALL patient 40, peripheral blood biological source: homo sapiens, ALL ex vivo material from adult B-ALL patient, peripheral blood taken prior to treatment, leukocyte isolation CD10 targeted enrichment for malignant blasts, cultivated in the presence of dexamethasone 10e-7M for 24h biological source: homo sapiens, ALL ex vivo material from adult B-ALL patient, peripheral blood taken prior to treatment, leukocyte isolation CD10 targeted enrichment for malignant blasts, cultivated in the presence of dexamethasone 10e-7M for 24h
GSM60543
GPL570
S-Line-C7H2-6h-GC C7H2 cell line homo sapiens , C7H2 cell line is a GC-sensitive subclone of CCRF-CEM (ATCC no. CCL-119), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethansone 10e-7M for 6h biological source: homo sapiens , C7H2 cell line is a GC-sensitive subclone of CCRF-CEM (ATCC no. CCL-119), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethansone 10e-7M for 6h
GSM60544
GPL570
S-Line-C7H2-24h-GC C7H2 cell line homo sapiens , C7H2 cell line is a GC-sensitive subclone of CCRF-CEM (ATCC no. CCL-119), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethansone 10e-7M for 24h biological source: homo sapiens , C7H2 cell line is a GC-sensitive subclone of CCRF-CEM (ATCC no. CCL-119), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethansone 10e-7M for 24h
GSM60545
GPL570
S-Line-PreB-6h-EtOH PreB 697 cell line homo sapiens, human B cell precursor leukemia cell line: 697 (DSMZ no: ACC 42), 697 cells are GC-sensitive, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of ethanol 0,1% for 6h biological source: homo sapiens, human B cell precursor leukemia cell line: 697 (DSMZ no: ACC 42), 697 cells are GC-sensitive, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of ethanol 0,1% for 6h
GSM60546
GPL570
S-Line-PreB-6h-GC PreB 697 cell line homo sapiens, human B cell precursor leukemia cell line: 697 (DSMZ no: ACC 42), 697 cells are GC-sensitive, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethansone 10e-7M for 6h biological source: homo sapiens, human B cell precursor leukemia cell line: 697 (DSMZ no: ACC 42), 697 cells are GC-sensitive, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethansone 10e-7M for 6h
GSM60547
GPL570
S-Line-PreB-24h-GC PreB 697 cell line homo sapiens, human B cell precursor leukemia cell line: 697 (DSMZ no: ACC 42), 697 cells are GC-sensitive, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethansone 10e-7M for 24h biological source: homo sapiens, human B cell precursor leukemia cell line: 697 (DSMZ no: ACC 42), 697 cells are GC-sensitive, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethansone 10e-7M for 24h
GSM60548
GPL570
C-Line-CEMC1-ratGR-6h-EtOH rat- Glucocorticoid-receptor transfected CCRF-CEM (ATCC no.: CLL-119) subclone C1 GC-sensitivity restored, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of ethanol 0,1% for 6h biological source: homo sapiens, rat- Glucocorticoid-receptor transfected CCRF-CEM (ATCC no.: CLL-119) subclone C1, parental cell line C1 = GC resistant, C1-rat-Glucocorticoid-receptor = GC-sensitivity restored, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of ethanol 0,1% for 6h
GSM60549
GPL570
C-Line-CEMC1-ratGR-6h-GC rat- Glucocorticoid-receptor transfected CCRF-CEM (ATCC no.: CLL-119) subclone C1 GC-sensitivity restored, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethansone 10e-7M for 6h biological source: homo sapiens, rat-Glucocorticoid-receptor transfected CCRF-CEM (ATCC no.: CLL-119) subclone C1, parental cell line C1 = GC resistant, C1-rat-GR = GC-sensitivity restored, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethansone 10e-7M for 6h
GSM60550
GPL570
C-Line-CEMC1-ratGR-24h-GC rat- Glucocorticoid-receptor transfected CCRF-CEM (ATCC no.: CLL-119) subclone C1 GC-sensitivity restored, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethansone 10e-7M for 24h biological source: homo sapiens, rat-Glucocorticoid-receptor transfected CCRF-CEM (ATCC no.: CLL-119) subclone C1, parental cell line C1 = GC resistant, C1-rat GR = GC-sensitivity restored, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethansone 10e-7M for 24h
GSM60551
GPL570
C-Line-C7R1dim-high-6h-EtOH C7R1 dim-high cell line homo sapiens, CCRF-CEM (ATCC no.: CLL-119) subclone C7R1 (=GC-resistant) transfected with a dimerization deficient Glucocorticoid-receptor-mutant, high expression of mutant resulting in a restored GC-sensitivity, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of ethanol 0,1% for 6h biological source: homo sapiens, CCRF-CEM (ATCC no.: CLL-119) subclone C7R1 (=GC-resistant) transfected with a dimerization deficient Glucocorticoid-receptor-mutant, high expression of mutant resulting in a restored GC-sensitivity, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of ethanol 0,1% for 6h
GSM60552
GPL570
C-Line-C7R1dim-high-6h-GC C7R1 dim-high cell line homo sapiens, CCRF-CEM (ATCC no.: CLL-119) subclone C7R1 (=GC-resistant) transfected with a dimerization deficient Glucocorticoid-receptor-mutant, high expression of mutant resulting in a restored GC-sensitivity, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethansone 10e-7M for 6h biological source: homo sapiens, CCRF-CEM (ATCC no.: CLL-119) subclone C7R1 (=GC-resistant) transfected with a dimerization deficient Glucocorticoid-receptor-mutant, high expression of mutant resulting in a restored GC-sensitivity, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethansone 10e-7M for 6h
GSM60553
GPL570
C-Line-C7R1dim-high-24h-GC C7R1 dim-high cell line homo sapiens, CCRF-CEM (ATCC no.: CLL-119) subclone C7R1 (=GC-resistant) transfected with a dimerization deficient Glucocorticoid-receptor-mutant, high expression of mutant resulting in a restored GC-sensitivity, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethansone 10e-7M for 24h biological source: homo sapiens, CCRF-CEM (ATCC no.: CLL-119) subclone C7R1 (=GC-resistant) transfected with a dimerization deficient Glucocorticoid-receptor-mutant, high expression of mutant resulting in a restored GC-sensitivity, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethansone 10e-7M for 24h
GSM60554
GPL570
CHX-C7H2-6h-EtOH C7H2 cell line homo sapiens , C7H2 cell line is a GC-sensitive subclone of CCRF-CEM (ATCC no. CCL-119), cultured under standard conditions (37°C, 5% CO2, saturated humidity),addition of cycloheximide 10ug/ml 3h prior to addition of ethanol 0,1%, incubation for 6h biological source: homo sapiens , C7H2 cell line is a GC-sensitive subclone of CCRF-CEM (ATCC no. CCL-119), cultured under standard conditions (37°C, 5% CO2, saturated humidity),addition of cycloheximide 10ug/ml 3h prior to addition of ethanol 0,1%, incubation for 6h
GSM60555
GPL570
CHX-C7H2-6h-GC C7H2 cell line homo sapiens , C7H2 cell line is a GC-sensitive subclone of CCRF-CEM (ATCC no. CCL-119), cultured under standard conditions (37°C, 5% CO2, saturated humidity), addition of cycloheximide 10ug/ml 3h prior to addition of dexamethansone 10e-7M, incubation for 6h biological source: homo sapiens , C7H2 cell line is a GC-sensitive subclone of CCRF-CEM (ATCC no. CCL-119), cultured under standard conditions (37°C, 5% CO2, saturated humidity), addition of cycloheximide 10ug/ml 3h prior to addition of dexamethansone 10e-7M, incubation for 6h
GSM60560
GPL570
R-Line-CEMC1-6h-EtOH CEMC1 cell line homo sapiens, C1 is a GC-resistant subclone of CCRF-CEM (ATCC no. CLL-119), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of ethanol 0,1% for 6h biological source: homo sapiens, C1 is a GC-resistant subclone of CCRF-CEM (ATCC no. CLL-119), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of ethanol 0,1% for 6h
GSM60561
GPL570
R-Line-CEMC1-6h-GC CEMC1 cell line homo sapiens, C1 is a GC-resistant subclone of CCRF-CEM (ATCC no. CLL-119), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethasone 10e-7M for 6h biological source: homo sapiens, C1 is a GC-resistant subclone of CCRF-CEM (ATCC no. CLL-119), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethasone 10e-7M for 6h
GSM60562
GPL570
R-Line-CEMC1-24h-GC CEMC1 cell line homo sapiens, C1 is a GC-resistant subclone of CCRF-CEM (ATCC no. CLL-119), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethasone 10e-7M for 24h biological source: homo sapiens, C1 is a GC-resistant subclone of CCRF-CEM (ATCC no. CLL-119), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethasone 10e-7M for 24h
GSM60564
GPL570
R-Line-C7R1-6h-EtOH C7R1 cell line homo sapiens, C7R1 is a GC-resistant subclone of CCRF-CEM (ATCC no. CLL-119), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of ethanol 0.1%, for 6h biological source: homo sapiens, C7R1 is a GC-resistant subclone of CCRF-CEM (ATCC no. CLL-119), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of ethanol 0.1%, for 6h
GSM60566
GPL570
R-Line-C7R1-6h-GC C7R1 cell line homo sapiens, C7R1 is a GC-resistant subclone of CCRF-CEM (ATCC no. CLL-119), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethasone 10e-7M for 6h biological source: homo sapiens, C7R1 is a GC-resistant subclone of CCRF-CEM (ATCC no. CLL-119), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethasone 10e-7M for 6h
GSM60576
GPL570
R-Line-C7R1dim-low-6h-EtOH C7R1 dim-low cell line homo sapiens, CCRF-CEM (ATCC no. CLL-119) subclone C7R1 (=GC-resistant) transfected with a dimerization deficient Glucocorticoid-receptor-mutant, C7R1 dim-low shows low expression of mutant and GC-resistant phenotype, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of ethanol 0,1% for 6h biological source: homo sapiens, CCRF-CEM (ATCC no. CLL-119) subclone C7R1 (=GC-resistant) transfected with a dimerization deficient Glucocorticoid-receptor-mutant, C7R1 dim-low shows low expression of mutant and GC-resistant phenotype, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of ethanol 0,1% for 6h
GSM60578
GPL570
R-Line-C7R1dim-low-6h-GC C7R1 dim-low cell line homo sapiens, CCRF-CEM (ATCC no. CLL-119) subclone C7R1 (=GC-resistant) transfected with a dimerization deficient Glucocorticoid-receptor-mutant, C7R1 dim-low shows low expression of mutant and GC-resistant phenotype, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethasone 10e-7M for 6h biological source: homo sapiens, CCRF-CEM (ATCC no. CLL-119) subclone C7R1 (=GC-resistant) transfected with a dimerization deficient Glucocorticoid-receptor-mutant, C7R1 dim-low shows low expression of mutant and GC-resistant phenotype, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethasone 10e-7M for 6h
GSM60579
GPL570
R-Line-C7R1dim-low-24h-GC C7R1 dim-low cell line homo sapiens, CCRF-CEM (ATCC no. CLL-119) subcone C7R1 (=GC-resistant) transfected with a dimerization deficient Glucocorticoid-receptor-mutant, C7R1 dim-low shows low expression of mutant and GC-resistant phenotype, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethasone 10e-7M for 24h biological source: homo sapiens, CCRF-CEM (ATCC no. CLL-119) subcone C7R1 (=GC-resistant) transfected with a dimerization deficient Glucocorticoid-receptor-mutant, C7R1 dim-low shows low expression of mutant and GC-resistant phenotype, cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethasone 10e-7M for 24h
GSM60581
GPL570
R-Line-PreB-6h-EtOH PreB 697 R4G4 cell line GC-sensitive), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of ethanol 0,1% for 6h biological source: homo sapiens, GC-resistant subclone (obtained from limiting dilution in the presence of dexamethasone) of 697 cells (DSMZ no: ACC 42) (parental 697 cells = GC-sensitive), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of ethanol 0,1% for 6h
GSM60583
GPL570
R-Line-PreB-6h-GC PreB 697 R4G4 cell line GC-sensitive), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethasone 10e-7M for 6h biological source: homo sapiens, GC-resistant subclone (obtained from limiting dilution in the presence of dexamethasone) of 697 cells (DSMZ no: ACC 42) (parental 697 cells = GC-sensitive), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethasone 10e-7M for 6h
GSM60584
GPL570
R-Line-PreB-24h-EtOH PreB 697 R4G4 cell line GC-sensitive), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of ethanol 0,1% for 24h biological source: homo sapiens, GC-resistant subclone (obtained from limiting dilution in the presence of dexamethasone) of 697 cells (DSMZ no: ACC 42) (parental 697 cells = GC-sensitive), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of ethanol 0,1% for 24h
GSM60586
GPL570
R-Line-PreB-24h-GC PreB 697 R4G4 cell line GC-sensitive), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethasone 10e-7M for 24h biological source: homo sapiens, GC-resistant subclone (obtained from limiting dilution in the presence of dexamethasone) of 697 cells (DSMZ no: ACC 42) (parental 697 cells = GC-sensitive), cultured under standard conditions (37°C, 5% CO2, saturated humidity), in the presence of dexamethasone 10e-7M for 24h
GSM60588
GPL570
HD1-STS-0h healthy donor HD1, peripheral blood biological source: homo sapiens, healthy donor (male, aged 32.8 years), peripheral blood taken prior to GC-administration, leukocyte isolation. biological source: homo sapiens, healthy donor (male, aged 32.8 years), peripheral blood taken prior to GC-administration, leukocyte isolation.
GSM60589
GPL570
HD1-STS-6h healthy donor HD1, peripheral blood biological source: homo sapiens, healthy donor (male, aged 32.8 years), peripheral blood taken 6h after GC-administration (33% of 60mg/m2 prednisolon) , leukocyte isolation biological source: homo sapiens, healthy donor (male, aged 32.8 years), peripheral blood taken 6h after GC-administration (33% of 60mg/m2 prednisolon) , leukocyte isolation
GSM60590
GPL570
HD1-STS-24h healthy donor HD1, peripheral blood biological source: homo sapiens, healthy donor (male, aged 32.8 years), peripheral blood taken 24h after first GC-administration, total GC-administration 33% of 60mg/m2 prednisolon + 1/3 of 66% of 60mg/m2 biological source: homo sapiens, healthy donor (male, aged 32.8 years), peripheral blood taken 24h after first GC-administration, total GC-administration 33% of 60mg/m2 prednisolon + 1/3 of 66% of 60mg/m2
GSM60591
GPL570
HD2-RPK-0h healthy donor HD2, peripheral blood biological source: homo sapiens, healthy donor (male, aged 54.8 years), peripheral blood taken prior to GC-administration, leukocyte isolation. biological source: homo sapiens, healthy donor (male, aged 54.8 years), peripheral blood taken prior to GC-administration, leukocyte isolation.
GSM60592
GPL570
HD2-RPK-6h healthy donor HD2, peripheral blood biological source: homo sapiens, healthy donor (male, aged 54.8 years), peripheral blood taken 6h after GC-administration (33% of 60mg/m2 prednisolon) , leukocyte isolation biological source: homo sapiens, healthy donor (male, aged 54.8 years), peripheral blood taken 6h after GC-administration (33% of 60mg/m2 prednisolon) , leukocyte isolation
GSM60593
GPL570
HD2-RPK-24h healthy donor HD2, peripheral blood biological source: homo sapiens, healthy donor (male, aged 54.8 years), peripheral blood taken 24h after first GC-administration, total GC-administration 33% of 60mg/m2 prednisolon + 1/3 of 66% of 60mg/m2 biological source: homo sapiens, healthy donor (male, aged 54.8 years), peripheral blood taken 24h after first GC-administration, total GC-administration 33% of 60mg/m2 prednisolon + 1/3 of 66% of 60mg/m2
GSM60594
GPL570
T-ALL-25-6h-5ug-rep T-ALL patient 25, peripheral blood biological source: homo sapiens, childhood ALL patient (female, aged 10.3 years), peripheral blood taken after 6 hours of treatment, leukocyte isolation followed by enrichment for malignant blasts by non-malignant cell depletion. biological source: homo sapiens, childhood ALL patient (female, aged 10.3 years), peripheral blood taken after 6 hours of treatment, leukocyte isolation followed by enrichment for malignant blasts by non-malignant cell depletion.
GSM60595
GPL570
T-ALL-25-6h-1ug-rep T-ALL patient 25, peripheral blood biological source: homo sapiens, childhood ALL patient (female, aged 10.3 years), peripheral blood taken after 6 hours of treatment, leukocyte isolation followed by enrichment for malignant blasts by non-malignant cell depletion. biological source: homo sapiens, childhood ALL patient (female, aged 10.3 years), peripheral blood taken after 6 hours of treatment, leukocyte isolation followed by enrichment for malignant blasts by non-malignant cell depletion.
GSM60597
GPL570
B-ALL-32-0h-rep1 B-ALL patient 32, peripheral blood biological source: homo sapiens, childhood ALL patient (female, aged 3.7 years), peripheral blood taken prior to treatment, leukocyte isolation followed by enrichment for malignant blasts by malignant cell selection (CD10). biological source: homo sapiens, childhood ALL patient (female, aged 3.7 years), peripheral blood taken prior to treatment, leukocyte isolation followed by enrichment for malignant blasts by malignant cell selection (CD10).
GSM60599
GPL570
B-ALL-32-0h-rep2 B-ALL patient 32, peripheral blood biological source: homo sapiens, childhood ALL patient (female, aged 3.7 years), peripheral blood taken prior to treatment, leukocyte isolation followed by enrichment for malignant blasts by malignant cell selection (CD10). technical replicate to sample B-ALL-32-0h-rep1 biological source: homo sapiens, childhood ALL patient (female, aged 3.7 years), peripheral blood taken prior to treatment, leukocyte isolation followed by enrichment for malignant blasts by malignant cell selection (CD10). technical replicate to sample B-ALL-32-0h-rep1
GSM60601
GPL570
B-ALL-37-BM-sorted B-ALL patient 37, bone marrow biological source: homo sapiens, childhood ALL patient (female, aged 15.1 years), bone marrow taken prior to treatment, leukocyte isolation followed by enrichment for malignant blasts by malignant cell selection (CD10). biological source: homo sapiens, childhood ALL patient (female, aged 15.1 years), bone marrow taken prior to treatment, leukocyte isolation followed by enrichment for malignant blasts by malignant cell selection (CD10).
GSM60603
GPL570
B-ALL-37-BM-unsorted B-ALL patient 37, bone marrow biological source: homo sapiens, childhood ALL patient (female, aged 15.1 years), bone marrow taken prior to treatment, leukocyte isolation without enrichment for malignant blasts. biological source: homo sapiens, childhood ALL patient (female, aged 15.1 years), bone marrow taken prior to treatment, leukocyte isolation without enrichment for malignant blasts.
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes